Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
CNY 36.21
(9.99%)
CNY 36.21
(9.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 10.7 Billion CNY | 7.52% |
| 2022 | 9.95 Billion CNY | 3.5% |
| 2021 | 9.61 Billion CNY | 7.68% |
| 2020 | 8.93 Billion CNY | -15.85% |
| 2019 | 10.61 Billion CNY | 8.97% |
| 2018 | 9.73 Billion CNY | 66.0% |
| 2017 | 5.86 Billion CNY | 58.09% |
| 2016 | 3.71 Billion CNY | 13.92% |
| 2015 | 3.25 Billion CNY | -4.62% |
| 2014 | 3.41 Billion CNY | 9.5% |
| 2013 | 3.11 Billion CNY | 24.22% |
| 2012 | 2.51 Billion CNY | 13.99% |
| 2011 | 2.2 Billion CNY | 33.27% |
| 2010 | 1.65 Billion CNY | 31.71% |
| 2009 | 1.25 Billion CNY | 32.32% |
| 2008 | 948.38 Million CNY | 29.6% |
| 2007 | 731.76 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 2.89 Billion CNY | -15.11% |
| 2024 Q1 | 3.4 Billion CNY | 22.11% |
| 2024 Q3 | 2.37 Billion CNY | -15.39% |
| 2023 Q1 | 3.07 Billion CNY | 26.55% |
| 2023 Q4 | 2.79 Billion CNY | 6.79% |
| 2023 FY | 10.7 Billion CNY | 7.52% |
| 2023 Q3 | 2.61 Billion CNY | -1.11% |
| 2023 Q2 | 2.64 Billion CNY | -14.03% |
| 2022 Q1 | 2.38 Billion CNY | -6.01% |
| 2022 Q4 | 2.42 Billion CNY | -5.84% |
| 2022 FY | 9.95 Billion CNY | 3.5% |
| 2022 Q3 | 2.58 Billion CNY | 0.81% |
| 2022 Q2 | 2.55 Billion CNY | 7.43% |
| 2021 Q1 | 2.27 Billion CNY | -6.51% |
| 2021 Q3 | 2.46 Billion CNY | 5.28% |
| 2021 Q4 | 2.53 Billion CNY | 2.9% |
| 2021 Q2 | 2.34 Billion CNY | 2.73% |
| 2021 FY | 9.61 Billion CNY | 7.68% |
| 2020 FY | 8.93 Billion CNY | -15.85% |
| 2020 Q2 | 2.09 Billion CNY | 16.16% |
| 2020 Q4 | 2.43 Billion CNY | -6.15% |
| 2020 Q3 | 2.59 Billion CNY | 23.93% |
| 2020 Q1 | 1.8 Billion CNY | -34.69% |
| 2019 Q3 | 2.5 Billion CNY | -11.89% |
| 2019 Q1 | 2.49 Billion CNY | -0.23% |
| 2019 Q2 | 2.84 Billion CNY | 13.82% |
| 2019 FY | 10.61 Billion CNY | 8.97% |
| 2019 Q4 | 2.76 Billion CNY | 10.15% |
| 2018 Q1 | 2.27 Billion CNY | 8.2% |
| 2018 Q4 | 2.5 Billion CNY | -6.4% |
| 2018 Q3 | 2.67 Billion CNY | 17.4% |
| 2018 FY | 9.73 Billion CNY | 66.0% |
| 2018 Q2 | 2.28 Billion CNY | 0.13% |
| 2017 Q2 | 1.14 Billion CNY | 6.88% |
| 2017 FY | 5.86 Billion CNY | 58.09% |
| 2017 Q4 | 2.1 Billion CNY | 35.25% |
| 2017 Q3 | 1.55 Billion CNY | 36.5% |
| 2017 Q1 | 1.06 Billion CNY | -4.28% |
| 2016 Q4 | 1.11 Billion CNY | 24.42% |
| 2016 FY | 3.71 Billion CNY | 13.92% |
| 2016 Q1 | 841.4 Million CNY | -2.26% |
| 2016 Q2 | 859.94 Million CNY | 2.2% |
| 2016 Q3 | 895.58 Million CNY | 4.14% |
| 2015 Q4 | 860.83 Million CNY | 4.72% |
| 2015 FY | 3.25 Billion CNY | -4.62% |
| 2015 Q3 | 822 Million CNY | 3.79% |
| 2015 Q2 | 791.97 Million CNY | 1.15% |
| 2015 Q1 | 782.97 Million CNY | -10.28% |
| 2014 Q3 | 873.1 Million CNY | -3.74% |
| 2014 Q1 | 762.74 Million CNY | -11.21% |
| 2014 FY | 3.41 Billion CNY | 9.5% |
| 2014 Q4 | 872.72 Million CNY | -0.04% |
| 2014 Q2 | 907.03 Million CNY | 18.92% |
| 2013 Q2 | 812.4 Million CNY | 29.85% |
| 2013 Q3 | 822.17 Million CNY | 1.2% |
| 2013 FY | 3.11 Billion CNY | 24.22% |
| 2013 Q4 | 859.02 Million CNY | 4.48% |
| 2013 Q1 | 625.62 Million CNY | -10.03% |
| 2012 Q3 | 702.78 Million CNY | 7.64% |
| 2012 Q1 | 460.01 Million CNY | -21.92% |
| 2012 Q4 | 695.35 Million CNY | -1.06% |
| 2012 Q2 | 652.9 Million CNY | 41.93% |
| 2012 FY | 2.51 Billion CNY | 13.99% |
| 2011 Q1 | 437.59 Million CNY | -14.89% |
| 2011 FY | 2.2 Billion CNY | 33.27% |
| 2011 Q4 | 589.19 Million CNY | -0.74% |
| 2011 Q3 | 593.58 Million CNY | 1.91% |
| 2011 Q2 | 582.47 Million CNY | 33.11% |
| 2010 Q3 | 432 Million CNY | 6.89% |
| 2010 Q2 | 404.16 Million CNY | 33.57% |
| 2010 Q1 | 302.58 Million CNY | -14.93% |
| 2010 Q4 | 514.15 Million CNY | 19.02% |
| 2010 FY | 1.65 Billion CNY | 31.71% |
| 2009 Q4 | 355.67 Million CNY | -0.31% |
| 2009 FY | 1.25 Billion CNY | 32.32% |
| 2009 Q3 | 356.78 Million CNY | 13.6% |
| 2009 Q2 | 314.07 Million CNY | 37.51% |
| 2009 Q1 | 228.39 Million CNY | 0.0% |
| 2008 FY | 948.38 Million CNY | 29.6% |
| 2007 FY | 731.76 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 2.18 Billion CNY | -388.676% |
| Zhejiang Zhenyuan Share Co., Ltd. | 762.64 Million CNY | -1303.243% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 458.96 Million CNY | -2231.696% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 187.93 Million CNY | -5594.422% |
| Yifan Pharmaceutical Co., Ltd. | 1.83 Billion CNY | -484.513% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 347.72 Million CNY | -2977.7% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 620.91 Million CNY | -1623.552% |
| Boai NKY Medical Holdings Ltd. | 894.38 Million CNY | -1096.55% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 808 Million CNY | -1224.476% |